Clinical TrialsSearch results
Number of results: 339
Other
- An open-label randomized trial of web-based educational program for diagnostic capability of skin tumor
- skin tumor
- Department of Epidemiology and Healthcare Research, Graduate School of Medicine, Kyoto University
- 2008-12-31
Other
- An open-label, randomized, controlled study of treatment duration of peginterferon alpha-2a monotherapy in patients with chronic hepatitis C
- Chronic hepatitis C with genotype 2a/2b or genotype 1b and low viral load (< 100 KIU/mL)
- Japanese Consortium for the Study of Liver Diseases
- 2008-03-31
Other
- An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C.
- Chronic hepatitis C with serogroup 1 and high viral load (>= 100 KIU/mL).
- Okayama University Hospital
- 2008-02-29
Completed
- ANCHOR-1
- Chronic rhinosinusitis with nasal polyps
- Sugiyama Yutaro
- 2022-05-28
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- assessment of immune system in child food after thymus extirpation at cardiac operation
- the patient with cardiopulmonary bupass in Infant
- TOKUSHIMA university
- 2009-07-27
Other
- Assessment study on validity of the Intervention Therapies for coronary artery disease in Japan
- Coronary artery disease
- National Hospital Organization
- 2007-09-01
Other
- biomarker study of the effect and adverse event for neoadjuvantchemotherapy with breast cancer patinets
- breast cancer
- national cancer center
- 2009-08-11
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Recruiting
- CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-11-11